Anthony Taparo has sold SGRY and made no open-market buys since May 2021
Chief Growth Officer at Surgery Partners, Inc.
SEC CIK 0001735245 · Filings on SEC.gov ↗
$0Bought
$4.8MSold
NoneLast buy
Every filing
11 filings since May 2021, newest first
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$43K−1.0%Mar 13
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$41K−1.0%Mar 6
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$37K−1.0%Feb 14
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$173K−6.0%Mar 15
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$221K−7.0%Mar 1
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$37K−1.0%Feb 15
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$268K−5.0%Mar 28
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$452K−8.0%Mar 17
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$36K−1.0%Mar 14
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$296K−5.0%Mar 2
SGRYSell
Surgery Partners, Inc.
Chief Growth Officer
$3.2M−37.0%May 10
Filings come from SEC EDGAR. Not investment advice.